Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Some Insider Action
View:
Post by aebestacey on Mar 06, 2017 10:58pm

Some Insider Action

Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Mar 3/17 Mar 3/17 Eldessouky Sam Direct Ownership Common Stock, no par value Form 3 : Initial Statement of Beneficial Ownership of Securities    
Mar 3/17 Mar 1/17 Eldessouky Sam Direct Ownership Non-Qualified Stock Options (right to purchase) A - Grant, award or other under Rule 16b-3(d) 31,430  
Mar 3/17 Mar 1/17 Humphries William D. Direct Ownership Non-Qualified Stock Options (right to purchase) A - Grant, award or other under Rule 16b-3(d) 150,859  
Mar 3/17 Mar 1/17 Appio Thomas Direct Ownership Non-Qualified Stock Options (right to purchase) A - Grant, award or other under Rule 16b-3(d) 30,174  
Mar 3/17 Mar 1/17 Ackermann Christina Direct Ownership Non-Qualified Stock Options (right to purchase) A - Grant, award or other under Rule 16b-3(d) 60,345  
Mar 3/17 Jan 6/17 Eldessouky Sam Direct Ownership Restricted Share Units A - Grant, award or other under Rule 16b-3(d) 8,534  
Mar 3/17 Jan 6/17 Eldessouky Sam Direct Ownership Common Stock, no par value A - Grant, award or other under Rule 16b-3(d)
Comment by kasperky on Mar 07, 2017 9:21am
Hi, are they buying? Are William and Thomas purchasing call options? Please explain. I'm a novice. Thank you.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse